Elin S. Gray

8.1k total citations · 1 hit paper
136 papers, 5.2k citations indexed

About

Elin S. Gray is a scholar working on Oncology, Immunology and Cancer Research. According to data from OpenAlex, Elin S. Gray has authored 136 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Oncology, 44 papers in Immunology and 41 papers in Cancer Research. Recurrent topics in Elin S. Gray's work include Cancer Genomics and Diagnostics (39 papers), HIV Research and Treatment (32 papers) and Cancer Immunotherapy and Biomarkers (31 papers). Elin S. Gray is often cited by papers focused on Cancer Genomics and Diagnostics (39 papers), HIV Research and Treatment (32 papers) and Cancer Immunotherapy and Biomarkers (31 papers). Elin S. Gray collaborates with scholars based in Australia, United States and South Africa. Elin S. Gray's co-authors include Mel Ziman, Lynn Morris, Penny L. Moore, Salim S. Abdool Karim, Michael Millward, Leslie Calapre, Carolyn Williamson, Koleka Mlisana, Pauline Zaenker and Tarek Meniawy and has published in prestigious journals such as Nature Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Elin S. Gray

130 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A scoping review of factors influencing the implementation of liquid biopsy for cancer care

2025 16 citations Lydia Warburton, Elin S. Gray et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elin S. Gray Australia	41	2.3k	1.9k	1.7k	1.3k	1.1k	136	5.2k
Yongping Yang United States	38	2.3k 1.0×	2.4k 1.3×	1.7k 1.0×	1.1k 0.8×	415 0.4×	120	6.9k
Kashi Javaherian United States	26	1.9k 0.8×	1.2k 0.6×	2.0k 1.2×	510 0.4×	736 0.7×	40	4.4k
Akifumi Takaori‐Kondo Japan	42	1.1k 0.5×	1.9k 1.0×	2.3k 1.3×	1.2k 0.9×	458 0.4×	288	5.8k
Meng Wang China	34	2.2k 1.0×	1.6k 0.9×	1.8k 1.1×	384 0.3×	285 0.3×	127	4.6k
Alexandre Harari Switzerland	40	1.3k 0.6×	3.5k 1.9×	1.3k 0.8×	1.4k 1.0×	149 0.1×	108	5.6k
Mark A. Goldsmith United States	44	1.9k 0.8×	2.9k 1.6×	1.2k 0.7×	1.5k 1.1×	224 0.2×	91	6.2k
Robert Balderas United States	35	987 0.4×	3.9k 2.1×	2.0k 1.2×	920 0.7×	223 0.2×	64	6.4k
Julie M. Cherrington United States	52	1.1k 0.5×	700 0.4×	3.7k 2.2×	2.3k 1.7×	1.1k 1.0×	88	8.9k
Keith C. Deen United States	20	1.0k 0.4×	1.5k 0.8×	1.7k 1.0×	750 0.6×	508 0.5×	37	3.6k

Countries citing papers authored by Elin S. Gray

Since Specialization

Citations

This map shows the geographic impact of Elin S. Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elin S. Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elin S. Gray more than expected).

Fields of papers citing papers by Elin S. Gray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elin S. Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elin S. Gray. The network helps show where Elin S. Gray may publish in the future.

Co-authorship network of co-authors of Elin S. Gray

This figure shows the co-authorship network connecting the top 25 collaborators of Elin S. Gray. A scholar is included among the top collaborators of Elin S. Gray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elin S. Gray. Elin S. Gray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Taaffe, Dennis R., Timothy Clay, Mauro De Santi, et al.. (2025). Effects of Resistance versus High-Intensity Interval Training on Myokines and Cancer Cell Suppression in Breast Cancer Survivors: A Randomized Trial. Medicine & Science in Sports & Exercise. 58(1). 1–9.

Gray, Elin S., et al.. (2024). Correlation of ctDNA and radiographic imaging features derived from ¹⁸F-FDG PET/CT for patients with metastatic melanoma treated with immunotherapy.. Journal of Clinical Oncology. 42(16_suppl). 3057–3057. 1 indexed citations

Beasley, Aaron B., David B. Preen, Samuel McLenachan, Elin S. Gray, & Fred K. Chen. (2023). Incidence and Mortality of Conjunctival Melanoma in Australia (1982 to 2014). Investigative Ophthalmology & Visual Science. 64(14). 2–2. 2 indexed citations

Francis, Roslyn J., et al.. (2023). 78 Application of novel AI-assisted technology in ¹⁸F-FDG PET-CT scan analysis – predicting disease response in metastatic melanoma patients undergoing immunotherapy. SHILAP Revista de lepidopterología. A88–A88.

Beasley, Aaron B., Robert M. Verdijk, Natasha M. van Poppelen, et al.. (2022). Is Tissue Still the Issue? The Promise of Liquid Biopsy in Uveal Melanoma. Biomedicines. 10(2). 506–506. 15 indexed citations

Beasley, Aaron B., Timothy Isaacs, Tersia Vermeulen, et al.. (2021). Analysis of Circulating Tumour Cells in Early-Stage Uveal Melanoma: Evaluation of Tumour Marker Expression to Increase Capture. Cancers. 13(23). 5990–5990. 9 indexed citations

Lee, Jenny, Alexander M. Menzies, Matteo S. Carlino, et al.. (2020). Longitudinal Monitoring of ctDNA in Patients with Melanoma and Brain Metastases Treated with Immune Checkpoint Inhibitors. Clinical Cancer Research. 26(15). 4064–4071. 62 indexed citations

Warburton, Lydia, Tarek Meniawy, Leslie Calapre, et al.. (2020). Stopping targeted therapy for complete responders in advanced BRAF mutant melanoma. Scientific Reports. 10(1). 18878–18878. 16 indexed citations

Warburton, Lydia, Leslie Calapre, Michelle R. Pereira, et al.. (2020). Circulating Tumour DNA in Advanced Melanoma Patients Ceasing PD1 Inhibition in the Absence of Disease Progression. Cancers. 12(11). 3486–3486. 11 indexed citations

10.

Morici, Michael, Xin Hong, Ryan J. Sullivan, et al.. (2020). Detection and prognostic role of heterogeneous populations of melanoma circulating tumour cells. British Journal of Cancer. 122(7). 1059–1067. 48 indexed citations

11.

Khattak, Muhammad A., Anna Reid, Ashleigh C. McEvoy, et al.. (2020). Role of Serum Vascular Endothelial Growth Factor (VEGF) as a Potential Biomarker of Response to Immune Checkpoint Inhibitor Therapy in Advanced Melanoma: Results of a Pilot Study. Frontiers in Oncology. 10. 1041–1041. 12 indexed citations

12.

Gray, Elin S., Michelle R. Pereira, Leslie Calapre, et al.. (2019). Genomic Analysis of Circulating Tumor DNA Using a Melanoma-Specific UltraSEEK Oncogene Panel. Journal of Molecular Diagnostics. 21(3). 418–426. 18 indexed citations

13.

Isaacs, Timothy, Aaron B. Beasley, Adnan Khattak, et al.. (2017). DETECTION OF CHROMOSOMAL ABERRATIONS ASSOCIATED WITH PROGNOSIS OF UVEAL MELANOMA USING CIRCULATING TUMOUR CELLS. Clinical and Experimental Ophthalmology. 45. 61–61. 1 indexed citations

14.

Richardson, Simone I., Elin S. Gray, Nonhlanhla N. Mkhize, et al.. (2014). The Sequence of the α4β7-binding Motif on Gp120 of Transmitted/Founder Viruses Contributes to the Dependence on the Integrin for HIV Infection. AIDS Research and Human Retroviruses. 30(S1). A56–A56. 1 indexed citations

15.

Calapre, Leslie, Elin S. Gray, & Mel Ziman. (2013). Heat stress: A risk factor for skin carcinogenesis. Cancer Letters. 337(1). 35–40. 44 indexed citations

16.

Freeman, James, Elin S. Gray, Michael Millward, Robert Pearce, & Mel Ziman. (2012). Evaluation of a multi-marker immunomagnetic enrichment assay for the quantification of circulating melanoma cells. Journal of Translational Medicine. 10(1). 192–192. 49 indexed citations

17.

Alexandre, Kabamba B., Elin S. Gray, Bronwen E. Lambson, et al.. (2010). Mannose-rich glycosylation patterns on HIV-1 subtype C gp120 and sensitivity to the lectins, Griffithsin, Cyanovirin-N and Scytovirin. Virology. 402(1). 187–196. 82 indexed citations

18.

Binley, James Μ., Emma T. Crooks, Michael S. Seaman, et al.. (2008). Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C. Journal of Virology. 82(23). 11651–11668. 278 indexed citations

19.

Gray, Elin S., Penny L. Moore, Ralph Pantophlet, & Lynn Morris. (2007). N-Linked Glycan Modifications in gp120 of Human Immunodeficiency Virus Type 1 Subtype C Render Partial Sensitivity to 2G12 Antibody Neutralization. Journal of Virology. 81(19). 10769–10776. 40 indexed citations

20.

Moore, Penny L., Elin S. Gray, Isaac Choge, et al.. (2007). The C3-V4 Region Is a Major Target of Autologous Neutralizing Antibodies in Human Immunodeficiency Virus Type 1 Subtype C Infection. Journal of Virology. 82(4). 1860–1869. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact